TGFBR2 and breast carcinoma: In similar studies, Tang et al. showed that introducing a dominant-negative TGFBR2 gene into highly metastatic MCF10Ca1 mammary carcinoma cells resulted in a reduction in experimental pulmonary metastases [24].